Iterum Therapeutics Plc (NASDAQ: ITRM)

Analyst Snapshot

How does ITRM’s price to cash per share ratio compare in the market?

Patricia Turner

Currently, Iterum Therapeutics Plc’s (ITRM) stock is trading at $0.3, marking a fall of -3.10% from last night’s close. At ...

Financial Scores

ITRM’s Q2 earnings predictions: What the experts say

Cameron Mitchell

Iterum Therapeutics Plc (ITRM)’s stock has witnessed a price hike of 1.01% from the previous close with its current price ...

US Post News
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.